Literature DB >> 18030239

Alemtuzumab for giant cell hepatitis with autoimmune hemolytic anemia.

Attilio Rovelli1, Paola Corti, Chiara Beretta, Giorgio Bovo, Valentino Conter, Giorgina Mieli-Vergani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18030239     DOI： 10.1097/MPG.0b013e318033169f

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  2 in total

1.  Giant cell hepatitis with autoimmune hemolytic anemia in a nine month old infant.

Authors:  Jihene Bouguila; Sameh Mabrouk; Samia Tilouche; Dajla Bakir; Amel Trabelsi; Amel Hmila; Lamia Boughammoura
Journal:  World J Hepatol       Date:  2013-04-27

2.  Successful Treatment of a Korean Infant with Giant Cell Hepatitis with Autoimmune Hemolytic Anemia Using Rituximab.

Authors:  Young Ho Kim; Ju Whi Kim; Eun Joo Lee; Gyeong Hoon Kang; Hyoung Jin Kang; Jin Soo Moon; Jae Sung Ko
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.